Human derived dimerization tag enhances tumor killing potency of a T-cell engaging bispecific antibody
出版年份 2015 全文链接
标题
Human derived dimerization tag enhances tumor killing potency of a T-cell engaging bispecific antibody
作者
关键词
-
出版物
OncoImmunology
Volume 4, Issue 4, Pages e989776
出版商
Informa UK Limited
发表日期
2015-04-28
DOI
10.4161/2162402x.2014.989776
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy
- (2014) Ming Cheng et al. INTERNATIONAL JOURNAL OF CANCER
- Neonatal Fc Receptor and its Role in the Absorption, Distribution, Metabolism and Excretion of Immunoglobulin G-Based Biotherapeutics
- (2013) Craig Giragossian et al. CURRENT DRUG METABOLISM
- A new class of bispecific antibodies to redirect T cells for cancer immunotherapy
- (2013) Diane L Rossi et al. mAbs
- The Immunogenicity of Polyethylene Glycol: Facts and Fiction
- (2013) Huub Schellekens et al. PHARMACEUTICAL RESEARCH
- Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells
- (2013) Y.-J. Liang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis
- (2012) Venkata Lokesh Battula et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of GD2 and GD3 Gangliosides in Human Embryonic Neural Stem Cells
- (2011) Makoto Yanagisawa et al. ASN Neuro
- EpCAM/CD3-Bispecific T-cell Engaging Antibody MT110 Eliminates Primary Human Pancreatic Cancer Stem Cells
- (2011) M. Cioffi et al. CLINICAL CANCER RESEARCH
- Bispecific antibodies engage T cells for antitumor immunotherapy
- (2011) Bryan D Choi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
- (2011) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- Redirected Lysis of Human Melanoma Cells by a MCSP/CD3-bispecific BiTE Antibody That Engages Patient-derived T Cells
- (2011) Hitoe Torisu-Itakura et al. JOURNAL OF IMMUNOTHERAPY
- GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells
- (2010) Hye Jin Jin et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cytotoxic Enhancement of a Bispecific Diabody by Format Conversion to Tandem Single-chain Variable Fragment (taFv)
- (2010) Ryutaro Asano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-GD2 with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia
- (2010) Linda S. Sorkin et al. PAIN
- T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells
- (2010) Ralf Lutterbuese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multivalent antibodies: when design surpasses evolution
- (2010) Ángel M. Cuesta et al. TRENDS IN BIOTECHNOLOGY
- Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
- (2009) T Osada et al. BRITISH JOURNAL OF CANCER
- Reducing Epitope Spread during Affinity Maturation of an Anti-Ganglioside GD2 Antibody
- (2009) J. Hu et al. JOURNAL OF IMMUNOLOGY
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now